DAVID LEE JOHNSON Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DAVID LEE JOHNSON.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DAVID LEE JOHNSON. DAVID LEE JOHNSON is Chief Commercial Officer in Global Blood Therapeutics, Inc. ($GBT).
Latest Insider Trading Transactions of DAVID LEE JOHNSON
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 02 2021 | GBT | Global Blood Thera ... | JOHNSON DAVID LEE | Chief Commercial Of ... | Option Exercise | M | 0.00 | 4,375 | 0 | 8,750 | |
| Apr 02 2021 | GBT | Global Blood Thera ... | JOHNSON DAVID LEE | Chief Commercial Of ... | Payment of Exercise | F | 42.62 | 1,513 | 64,484 | 30,269 | 31.8 K to 30.3 K (-4.76 %) |
| Apr 02 2021 | GBT | Global Blood Thera ... | JOHNSON DAVID LEE | Chief Commercial Of ... | Buy | M | 0.00 | 4,375 | 0 | 31,782 | 27.4 K to 31.8 K (+15.96 %) |
| Mar 03 2021 | GBT | Global Blood Thera ... | JOHNSON DAVID LEE | Chief Commercial Of ... | Option Exercise | A | 0.00 | 22,102 | 0 | 22,102 | |
| Mar 03 2021 | GBT | Global Blood Thera ... | JOHNSON DAVID LEE | Chief Commercial Of ... | Option Exercise | A | 44.48 | 38,739 | 1,723,111 | 38,739 | |
| Mar 03 2021 | GBT | Global Blood Thera ... | JOHNSON DAVID LEE | Chief Commercial Of ... | Grant | A | 36.21 | 375 | 13,579 | 27,407 | 27 K to 27.4 K (+1.39 %) |
| Feb 03 2021 | GBT | Global Blood Thera ... | JOHNSON DAVID LEE | Chief Commercial Of ... | Option Exercise | M | 0.00 | 3,645 | 0 | 21,870 | |
| Feb 03 2021 | GBT | Global Blood Thera ... | JOHNSON DAVID LEE | Chief Commercial Of ... | Option Exercise | M | 0.00 | 3,125 | 0 | 12,500 | |
| Feb 03 2021 | GBT | Global Blood Thera ... | JOHNSON DAVID LEE | Chief Commercial Of ... | Payment of Exercise | F | 49.49 | 2,458 | 121,646 | 27,032 | 29.5 K to 27 K (-8.34 %) |
| Feb 03 2021 | GBT | Global Blood Thera ... | JOHNSON DAVID LEE | Chief Commercial Of ... | Buy | M | 0.00 | 6,770 | 0 | 29,490 | 22.7 K to 29.5 K (+29.80 %) |
| Aug 04 2020 | GBT | Global Blood Thera ... | JOHNSON DAVID LEE | Chief Commercial Of ... | Option Exercise | M | 0.00 | 3,645 | 0 | 25,515 | |
| Aug 04 2020 | GBT | Global Blood Thera ... | JOHNSON DAVID LEE | Chief Commercial Of ... | Option Exercise | M | 0.00 | 3,125 | 0 | 15,625 | |
| Aug 04 2020 | GBT | Global Blood Thera ... | JOHNSON DAVID LEE | Chief Commercial Of ... | Option Exercise | M | 0.00 | 3,645 | 0 | 25,515 | |
| Aug 04 2020 | GBT | Global Blood Thera ... | JOHNSON DAVID LEE | Chief Commercial Of ... | Payment of Exercise | F | 67.48 | 2,618 | 176,663 | 20,515 | 23.1 K to 20.5 K (-11.32 %) |
| Aug 04 2020 | GBT | Global Blood Thera ... | JOHNSON DAVID LEE | Chief Commercial Of ... | Option Exercise | M | 0.00 | 3,125 | 0 | 15,625 | |
| Aug 04 2020 | GBT | Global Blood Thera ... | JOHNSON DAVID LEE | Chief Commercial Of ... | Buy | M | 0.00 | 6,770 | 0 | 23,133 | 16.4 K to 23.1 K (+41.37 %) |
| Aug 04 2020 | GBT | Global Blood Thera ... | JOHNSON DAVID LEE | Chief Commercial Of ... | Payment of Exercise | F | 67.48 | 2,618 | 176,663 | 20,515 | 23.1 K to 20.5 K (-11.32 %) |
| Aug 04 2020 | GBT | Global Blood Thera ... | JOHNSON DAVID LEE | Chief Commercial Of ... | Grant | A | 36.68 | 316 | 11,591 | 16,363 | 16 K to 16.4 K (+1.97 %) |
| Aug 04 2020 | GBT | Global Blood Thera ... | JOHNSON DAVID LEE | Chief Commercial Of ... | Buy | M | 0.00 | 6,770 | 0 | 23,133 | 16.4 K to 23.1 K (+41.37 %) |
| Aug 04 2020 | GBT | Global Blood Thera ... | JOHNSON DAVID LEE | Chief Commercial Of ... | Grant | A | 36.68 | 316 | 11,591 | 16,363 | 16 K to 16.4 K (+1.97 %) |
| Jun 03 2020 | GBT | Global Blood Thera ... | JOHNSON DAVID LEE | Chief Commercial Of ... | Option Exercise | A | 0.00 | 42,400 | 0 | 42,400 | |
| Apr 03 2020 | GBT | Global Blood Thera ... | JOHNSON DAVID LEE | Chief Commercial Of ... | Option Exercise | M | 0.00 | 4,375 | 0 | 17,500 | |
| Apr 03 2020 | GBT | Global Blood Thera ... | JOHNSON DAVID LEE | Chief Commercial Of ... | Payment of Exercise | F | 48.73 | 1,513 | 73,728 | 16,047 | 17.6 K to 16 K (-8.62 %) |
| Apr 03 2020 | GBT | Global Blood Thera ... | JOHNSON DAVID LEE | Chief Commercial Of ... | Buy | M | 0.00 | 4,375 | 0 | 17,560 | 13.2 K to 17.6 K (+33.18 %) |
| Feb 04 2020 | GBT | Global Blood Thera ... | JOHNSON DAVID LEE | Chief Commercial Of ... | Option Exercise | A | 65.82 | 38,500 | 2,534,070 | 38,500 | |
| Feb 04 2020 | GBT | Global Blood Thera ... | JOHNSON DAVID LEE | Chief Commercial Of ... | Option Exercise | A | 0.00 | 29,160 | 0 | 29,160 | |
| Feb 04 2020 | GBT | Global Blood Thera ... | JOHNSON DAVID LEE | Chief Commercial Of ... | Option Exercise | M | 0.00 | 3,125 | 0 | 18,750 | |
| Feb 04 2020 | GBT | Global Blood Thera ... | JOHNSON DAVID LEE | Chief Commercial Of ... | Payment of Exercise | F | 65.26 | 1,167 | 76,158 | 13,185 | 14.4 K to 13.2 K (-8.13 %) |
| Feb 04 2020 | GBT | Global Blood Thera ... | JOHNSON DAVID LEE | Chief Commercial Of ... | Buy | M | 0.00 | 3,125 | 0 | 14,352 | 11.2 K to 14.4 K (+27.83 %) |
| Feb 04 2020 | GBT | Global Blood Thera ... | JOHNSON DAVID LEE | Chief Commercial Of ... | Grant | A | 36.68 | 310 | 11,371 | 11,227 | 10.9 K to 11.2 K (+2.84 %) |
| Oct 02 2019 | GBT | Global Blood Thera ... | JOHNSON DAVID LEE | Chief Commercial Of ... | Option Exercise | M | 0.00 | 4,375 | 0 | 21,875 | |
| Oct 02 2019 | GBT | Global Blood Thera ... | JOHNSON DAVID LEE | Chief Commercial Of ... | Payment of Exercise | F | 46.99 | 1,537 | 72,224 | 10,917 | 12.5 K to 10.9 K (-12.34 %) |
| Oct 02 2019 | GBT | Global Blood Thera ... | JOHNSON DAVID LEE | Chief Commercial Of ... | Buy | M | 0.00 | 4,375 | 0 | 12,454 | 8.1 K to 12.5 K (+54.15 %) |
| Aug 05 2019 | GBT | Global Blood Thera ... | JOHNSON DAVID LEE | Chief Commercial Of ... | Option Exercise | M | 0.00 | 3,125 | 0 | 21,875 | |
| Aug 05 2019 | GBT | Global Blood Thera ... | JOHNSON DAVID LEE | Chief Commercial Of ... | Payment of Exercise | F | 54.25 | 1,081 | 58,644 | 8,079 | 9.2 K to 8.1 K (-11.80 %) |
| Aug 05 2019 | GBT | Global Blood Thera ... | JOHNSON DAVID LEE | Chief Commercial Of ... | Buy | M | 0.00 | 3,125 | 0 | 9,160 | 6 K to 9.2 K (+51.78 %) |
| Aug 05 2019 | GBT | Global Blood Thera ... | JOHNSON DAVID LEE | Chief Commercial Of ... | Grant | A | 36.68 | 311 | 11,407 | 6,035 | 5.7 K to 6 K (+5.43 %) |
| Apr 02 2019 | GBT | Global Blood Thera ... | JOHNSON DAVID LEE | Chief Commercial Of ... | Option Exercise | M | 0.00 | 8,750 | 0 | 26,250 | |
| Apr 02 2019 | GBT | Global Blood Thera ... | JOHNSON DAVID LEE | Chief Commercial Of ... | Payment of Exercise | F | 52.90 | 3,026 | 160,075 | 5,724 | 8.8 K to 5.7 K (-34.58 %) |
| Apr 02 2019 | GBT | Global Blood Thera ... | JOHNSON DAVID LEE | Chief Commercial Of ... | Buy | M | 0.00 | 8,750 | 0 | 8,750 | 0 to 8.8 K |
| Feb 05 2019 | GBT | Global Blood Thera ... | JOHNSON DAVID LEE | Chief Commercial Of ... | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
| Feb 05 2019 | GBT | Global Blood Thera ... | JOHNSON DAVID LEE | Chief Commercial Of ... | Option Exercise | A | 48.44 | 40,000 | 1,937,600 | 40,000 |
Page: 1